Creative Planning
BLCM

Creative Planning’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Creative Planning’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,098
Closed -$223K – 2134
2019
Q2 		$223K Hold
13,098
– – ﹤0.01% 1545
2019
Q1 		$441K Hold
13,098
– – ﹤0.01% 1106
2018
Q4 		$382K Sell
13,098
-2,632
-17% -$117K ﹤0.01% 1097
2018
Q3 		$969K Buy
15,730
+300
+2% +$20.3K ﹤0.01% 779
2018
Q2 		$1.14M Sell
15,430
-25
-0.2% -$1.95K ﹤0.01% 686
2018
Q1 		$1.01M Sell
15,455
-100
-0.6% -$7.55K ﹤0.01% 730
2017
Q4 		$1.31M Sell
15,555
-10
-0.1% -$981 0.01% 592
2017
Q3 		$1.8M Buy
15,565
+3,876
+33% +$408K 0.01% 499
2017
Q2 		$1.36M Buy
11,689
+4,779
+69% +$593K 0.01% 559
2017
Q1 		$853K Hold
6,910
– – ﹤0.01% 733
2016
Q4 		$941K Buy
6,910
+3,880
+128% +$689K 0.01% 651
2016
Q3 		$603K Hold
3,030
– – ﹤0.01% 799
2016
Q2 		$393K Sell
3,030
-40
-1% -$4.45K ﹤0.01% 905
2016
Q1 		$287K Buy
3,070
+40
+1% +$4.36K ﹤0.01% 1014
2015
Q4 		$614K Buy
3,030
+1,530
+102% +$274K 0.01% 673
2015
Q3 		$218K Buy
1,500
+180
+14% +$33K ﹤0.01% 1150
2015
Q2 		$281K Buy
+1,320
New +$324K ﹤0.01% 812

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Creative Planning's BLCM Position: Q3 2019 in Review

Creative Planning sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 13,098 shares — an estimated $223K sold.

Creative Planning first reported a position in BLCM in Q2 2015 and held it in 17 quarters. The position peaked at $1.8M in Q3 2017. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Creative Planning reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Creative Planning sold 13,098 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $223K.
  • Creative Planning first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 17 quarters.
  • Creative Planning's Bellicum Pharmaceuticals, Inc. position peaked at $1.8M in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.